Positive findings in the PrimECC study

The PrimECC® study was completed during 2017. It included a total of 80 patients and was performed at Sahlgrenska University Hospital. Analysis of the results shows that the product is safe and indicates interesting findings regarding decreased side effects when using PrimECC®. To expand the documentation and spread the use of PrimECC®, the company has decided on further studies. PrimECC® is a CE-marked and patent-protected product, developed to prime the heart-lung machine before open heart surgery.Several hundred thousand heart operations are performed in the world each year using a heart-